Showing results (141-150 of 651) with videos related to
Sort By:
Pageof 66
Neuropsychopharmacology Reports|April 30, 2024
Post-marketing surveillance of quetiapine fumarate extended-release tablets in patients with bipolar depressionTaro Kishi, Nakao Iwata, Hiroyuki Irie, et al.Neuropsychopharmacology Reports|May 8, 2024
Evaluation of the effect of Modafinil in the improvement of the level of consciousness in patients with COVID-19 encephalopathy: A randomized controlled trialFatemeh Talebi Kiasari, Mobin Naghshbandi, Maziar Emamikhah, et al.Neuropsychopharmacology Reports|April 16, 2024
Comparison of patients with benzodiazepine receptor agonist-related psychiatric disorders and over-the-counter drug-related psychiatric disorders before and after the COVID-19 pandemic: Changes in psychosocial characteristics and types of abused drugsTakashi Usami, Kyoji Okita, Takuya Shimane, et al.Neuropsychopharmacology Reports|June 14, 2026
Clopidogrel, an ADP-P2Y12 Receptor Antagonist, Is Associated With Lower Opioid Consumption and a Reduced Incidence of Delirium in Cancer Patients Receiving Chemotherapy: A Nationwide Retrospective Cohort Study in JapanHiroaki Abe, Reo Inoue, Takamichi Kogure, et al.Neuropsychopharmacology Reports|June 17, 2026
Changes in White Blood Cell and Neutrophil Counts in Patients With Schizophrenia Treated With Lithium Carbonate, Adenine, and Ninjin-Yoei-To: A Preliminary StudyTeruyuki Matsuoka, Sumihiro YamanoNeuropsychopharmacology Reports|June 17, 2026
Vipr2 Gene Expression Is Upregulated in the Nucleus Accumbens of Spontaneous Hypertensive Rats During Early LifeRyota Araki, Ayami Kita, Yukio Ago, et al.Neuropsychopharmacology Reports|July 3, 2026
Comment on "Serum Amyloid β Oligomer May Predict Treatment Response in Middle-Aged and Late-Life Patients With Depression"Stjepan ŠkudarNeuropsychopharmacology Reports|July 28, 2026
Is Aripiprazole an Effective Adjunct to Reduce Metabolic Adverse Effects Caused by Clozapine in Patients With Schizophrenia-A Systematic ReviewAvtaar Singh, Soban SadiqNeuropsychopharmacology Reports|July 21, 2026
The "GABAergic Brake" on the Spinal Defecation Reflex: A Proposed Neurobiological Model Explaining Clozapine- and Benzodiazepine-Induced Gastrointestinal Hypomotility and Ogilvie's SyndromeTakahiko NagamineNeuropsychopharmacology Reports|August 6, 2026
Possible Contribution of Multiple Sclerosis Pathology to Treatment-Resistant Schizophrenia: A Case StudySho Miura, Atsuko Nagaoka, Mizuki Hino, et al.Pageof 66